Horse tranquilliser trial is awarded $750,000 grant for Parkinson’s research

News

Author: Simge Eva DoganPublished: 26 July 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

ketamine

Researchers at the University of Arizona College of Medicine, Tucson, US, will be trialling ketamine – a recreational drug previously used to medicate people with depression – as a treatment for Parkinson’s.

The research – led by Dr Scott Sherman – is being supported with a three-year grant of $750,000 from the Arizona Biomedical Research Commission.

The initial clinical trial will test the effect of ketamine for treating dyskinesia in 10 patients. In addition, the researchers will carry out a separate rodent study to examine how the drug affects the brain.

Dr Scott Sherman, a neurologist at the University of Arizona College of Medicine, said: “Ketamine has been long overlooked. Now it could prove very useful for Parkinson’s patients.”

For information on the latest Parkinson’s research please visit the European Parkinson’s Disease Association website.

For more information on this article click here.

Go Back

Share this story

Comments


Related articles


A picture of a cough medicine bottle with two packets of pills on a table

Advances

Could a cough medicine help slow the progression of Parkinson’s disease?

Researchers say this trial is “a big step forward”

READ MORE
MDS Summer School for Nurses

PD in Practice

Aspiring Parkinson’s nurses urged to apply for “hands-on” summer school in Portugal

A unique opportunity to bring Parkinson’s nurses together

READ MORE
Roast squash salad Parkinson's nutrition

Recipes & nutrition

Nutritious summer salad for people with Parkinson’s

Try this recipe for a roast squash, bean, spinach and rocket salad

READ MORE